HealthLynked Corp. (HLYK)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
HealthLynked Corp. (HLYK) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 46/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 15. März 2026HealthLynked Corp. (HLYK) Gesundheitswesen & Pipeline-Uebersicht
HealthLynked Corp. provides a cloud-based patient information network and healthcare services, including digital health solutions, ACO/MSO services, and medical distribution. The company aims to streamline medical data management and improve patient-provider communication within the fragmented U.S. healthcare landscape, but faces challenges in scaling its integrated platform.
Investmentthese
HealthLynked Corp. presents a unique investment opportunity within the digital healthcare space, focusing on patient data management and connectivity. With a market capitalization of $0.01 billion, the company's growth potential hinges on the expansion of its HealthLynked Network and the increasing adoption of its ACO/MSO services. Key value drivers include the ability to attract and retain physician practices within its network and the successful execution of its medical distribution strategy. The company's high gross margin of 97.8% indicates potential for profitability if it can achieve scale. However, the negative P/E ratio of -2.96 and a negative profit margin of -161.5% highlight significant financial challenges. The company's beta of 2.20 suggests high volatility, reflecting the speculative nature of the stock. Successful expansion of its digital healthcare services and effective cost management are critical for realizing its growth potential.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.01 billion indicates a micro-cap company with high growth potential but also significant risk.
- Gross margin of 97.8% suggests a strong pricing power or efficient cost management in its service offerings.
- Negative P/E ratio of -2.96 reflects current unprofitability, indicating a need for improved operational efficiency or revenue growth.
- Beta of 2.20 indicates high volatility compared to the market, suggesting a speculative investment.
- Operates in four divisions: Health Services, Digital HealthCare, ACO/MSO, and Medical Distribution, providing diversified revenue streams but also operational complexity.
Wettbewerber & Vergleichsunternehmen
Staerken
- Integrated platform offering a range of healthcare services.
- Cloud-based patient information network for efficient data management.
- High gross margin of 97.8% indicating strong pricing power.
- Diverse revenue streams across four divisions.
Schwaechen
- Negative P/E ratio and profit margin indicating current unprofitability.
- Small market capitalization and limited financial resources.
- High beta indicating high volatility and speculative nature.
- Dependence on attracting and retaining physician practices.
Katalysatoren
- Ongoing: Expansion of the HealthLynked Network to include more patients and providers.
- Ongoing: Growth in ACO/MSO services due to increasing adoption of value-based care.
- Ongoing: Expansion of the medical distribution division to offer a wider range of products.
- Upcoming: Potential strategic partnerships or acquisitions to expand capabilities and market reach.
- Ongoing: Expansion of telehealth services to provide remote consultations and monitoring to patients.
Risiken
- Ongoing: Intense competition from larger, more established players in the digital health market.
- Potential: Regulatory changes and healthcare reform impacting the ACO/MSO business.
- Potential: Cybersecurity risks and data breaches compromising patient data.
- Potential: Economic downturn impacting patient spending on healthcare services.
- Ongoing: Limited liquidity due to low trading volume on the OTC market.
Wachstumschancen
- Expansion of the HealthLynked Network: The company can grow by expanding its HealthLynked Network to include more patients and providers. The global digital health market is projected to reach $660 billion by 2025, providing a significant opportunity for HealthLynked to increase its market share. Timeline: Ongoing, with continuous efforts to onboard new users and integrate with existing healthcare systems.
- Growth in ACO/MSO Services: The increasing adoption of value-based care models and the Medicare Shared Savings Program presents a growth opportunity for HealthLynked's ACO/MSO division. The ACO market is expected to reach $60 billion by 2027. Timeline: Ongoing, with continuous efforts to expand its ACO/MSO services to more physician practices.
- Medical Distribution Division Expansion: The company can expand its medical distribution division by offering a wider range of discounted medical supplies to consumers and medical practices. The global medical supplies market is projected to reach $170 billion by 2028. Timeline: Ongoing, with continuous efforts to expand its product offerings and distribution channels.
- Strategic Partnerships and Acquisitions: HealthLynked can pursue strategic partnerships or acquisitions to expand its capabilities and market reach. This could include partnerships with other digital health companies, healthcare providers, or technology companies. Timeline: Potential, with ongoing evaluation of potential partnership and acquisition opportunities.
- Telehealth Services Expansion: HealthLynked can expand its telehealth services to provide remote consultations and monitoring to patients. The telehealth market is expected to reach $175 billion by 2026, driven by increasing demand for remote healthcare services. Timeline: Ongoing, with continuous efforts to expand its telehealth offerings and integrate them into its HealthLynked Network.
Chancen
- Expansion of the HealthLynked Network to increase market share.
- Growth in ACO/MSO services due to increasing adoption of value-based care.
- Expansion of the medical distribution division to offer a wider range of products.
- Strategic partnerships and acquisitions to expand capabilities and market reach.
Risiken
- Intense competition from larger, more established players in the digital health market.
- Regulatory changes and healthcare reform impacting the ACO/MSO business.
- Cybersecurity risks and data breaches compromising patient data.
- Economic downturn impacting patient spending on healthcare services.
Wettbewerbsvorteile
- Network effect: The HealthLynked Network becomes more valuable as more patients and providers join the platform.
- Integrated platform: The company offers a comprehensive suite of services, including patient data management, healthcare services, and medical distribution.
- Proprietary technology: The company's cloud-based platform and record archiving system provide a competitive advantage.
Ueber HLYK
HealthLynked Corp., incorporated in 2014 and headquartered in Naples, Florida, operates a cloud-based patient information network and record archiving system in the United States. The company's mission is to connect patients and healthcare providers through its digital platform, aiming to streamline medical data management and improve communication. HealthLynked operates through four divisions: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division offers obstetrical and gynecological medical services, functional medicine focusing on neurodegenerative diseases, and physical therapy through Bridging the Gap Physical Therapy. The Digital HealthCare division operates the HealthLynked Network, enabling patients and doctors to manage medical information via a cloud-based system. This segment also provides online scheduling for appointments. The ACO/MSO division assists physician practices in providing care through the Medicare Shared Savings Program and offers consulting services to healthcare providers and ACOs. The Medical Distribution Division functions as a virtual distributor of discounted medical supplies to consumers and medical practices. HealthLynked aims to create a comprehensive healthcare ecosystem, but faces competition from larger, more established players in the digital health and healthcare services markets.
Was das Unternehmen tut
- Operates a cloud-based patient information network.
- Provides a record archiving system for medical data.
- Offers obstetrical and gynecological medical services.
- Provides functional medicine focusing on neurodegenerative diseases.
- Offers physical therapy services through Bridging the Gap Physical Therapy.
- Operates an ACO and MSO to assist physician practices in providing care.
- Functions as a virtual distributor of discounted medical supplies.
Geschaeftsmodell
- Generates revenue from Health Services division through patient care and medical procedures.
- Earns revenue from Digital HealthCare division through subscriptions and licensing fees for the HealthLynked Network.
- Receives revenue from ACO/MSO division through consulting services and shared savings programs.
- Generates revenue from Medical Distribution division through the sale of discounted medical supplies.
Branchenkontext
HealthLynked Corp. operates within the rapidly evolving digital health market, which is experiencing significant growth due to increasing adoption of telehealth, electronic health records, and remote patient monitoring. The industry is characterized by intense competition, with established players like Cerner and Allscripts, as well as numerous startups vying for market share. HealthLynked's focus on patient data management and connectivity positions it within the broader trend of value-based care and personalized medicine. The company's success depends on its ability to differentiate itself through its integrated platform and attract a critical mass of patients and providers.
Wichtige Kunden
- Patients seeking medical care and access to their medical records.
- Physician practices looking to improve patient care and participate in shared savings programs.
- Healthcare providers seeking consulting services for ACO/MSO operations.
- Consumers and medical practices purchasing discounted medical supplies.
Finanzdaten
Chart & Info
HealthLynked Corp. (HLYK) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer HLYK verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer HLYK.
Kursziele
Wall-Street-Kurszielanalyse fuer HLYK.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von HLYK auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Michael Thomas Dent
CEO
Michael Thomas Dent serves as the CEO of HealthLynked Corp. His background includes experience in managing and growing healthcare-related businesses. He is responsible for the overall strategic direction and operational execution of the company. His leadership focuses on expanding HealthLynked's digital platform and healthcare service offerings. He oversees the company's four divisions and is involved in key decisions related to partnerships, acquisitions, and product development. He manages a team of approximately 20 employees.
Erfolgsbilanz: Under Michael Thomas Dent's leadership, HealthLynked has focused on expanding its HealthLynked Network and developing its ACO/MSO services. Key milestones include the growth of the company's digital platform and the expansion of its medical distribution division. He has focused on integrating the company's various divisions to create a comprehensive healthcare ecosystem. However, the company's financial performance remains a challenge, with ongoing efforts to achieve profitability.
HLYK OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that HealthLynked Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors and may be subject to greater risks. Unlike companies listed on the NYSE or NASDAQ, OTC Other companies do not have to adhere to stringent listing standards, resulting in less regulatory oversight and potentially higher information asymmetry.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight compared to NYSE or NASDAQ-listed companies.
- Potential for information asymmetry due to limited financial reporting.
- Higher risk of fraud or manipulation compared to regulated exchanges.
- Volatility due to speculative trading and limited institutional investment.
- Verify the company's financial statements and reporting frequency.
- Assess the trading volume and bid-ask spread to evaluate liquidity.
- Research the company's management team and their track record.
- Review the company's business model and competitive landscape.
- Consult with a financial advisor to assess the risks and suitability of the investment.
- Check for any regulatory actions or legal issues involving the company.
- Confirm the company's contact information and physical address.
- Operation since 2014 suggests some business viability.
- Presence of four distinct operating divisions indicates diversification.
- Focus on digital healthcare aligns with industry trends.
- CEO with experience in healthcare management.
- Headquarters located in Naples, Florida.
Haeufige Fragen zu HLYK
What are the key factors to evaluate for HLYK?
HealthLynked Corp. (HLYK) currently holds an AI score of 46/100, indicating low score. Key strength: Integrated platform offering a range of healthcare services.. Primary risk to monitor: Ongoing: Intense competition from larger, more established players in the digital health market.. This is not financial advice.
How frequently does HLYK data refresh on this page?
HLYK prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HLYK's recent stock price performance?
Recent price movement in HealthLynked Corp. (HLYK) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Integrated platform offering a range of healthcare services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider HLYK overvalued or undervalued right now?
Determining whether HealthLynked Corp. (HLYK) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying HLYK?
Before investing in HealthLynked Corp. (HLYK), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding HLYK to a portfolio?
Potential reasons to consider HealthLynked Corp. (HLYK) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Integrated platform offering a range of healthcare services.. Additionally: Cloud-based patient information network for efficient data management.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of HLYK?
Yes, most major brokerages offer fractional shares of HealthLynked Corp. (HLYK) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track HLYK's earnings and financial reports?
HealthLynked Corp. (HLYK) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for HLYK earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on the most recent available information.
- The analysis is based on publicly available information and may not reflect all relevant factors.
- AI analysis is pending for HLYK stock.